Multicenter, Open-Label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects with Known or Suspected Vascular Disease of the Supra-Aortic Vessels

The PI of this project was:

This project was funded by: Bayer

The term of this project was: September 2011 to October 2014

The number of subjects scanned during this project was: 15